[Skip to Content]
[Skip to Content Landing]
JAMA Insights
Clinical Update
January 29, 2019

Perioperative Glucose Control in Patients With Diabetes Undergoing Elective Surgery

Author Affiliations
  • 1Division of Endocrinology, Diabetes, and Metabolism, Mayo Clinic, Rochester, Minnesota
JAMA. 2019;321(4):399-400. doi:10.1001/jama.2018.20922

Hyperglycemia in the perioperative period is associated with several adverse outcomes including wound infection, pneumonia, sepsis, and cardiovascular events.1 Limited evidence suggests that good glucose control is likely to be beneficial in reducing postoperative mortality, length of hospital stay, and cardiovascular complications such as stroke.2 Guidelines for achieving good perioperative glucose control are available but lack sufficient detail.3 In this JAMA Insights article, we outline an easy-to-adopt approach for safe and effective perioperative management of hyperglycemia.